Last Posted: Aug 27, 2019
- Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina.
Cerretini Roxana et al. Breast cancer research and treatment 2019 Aug - Precision medicine: PI3K targeting in advanced breast cancer.
Rocca Andrea et al. Breast cancer research and treatment 2019 Aug - Case-Only Analysis of Gene-Environment Interactions Using Polygenic Risk Scores.
Meisner Allison et al. American journal of epidemiology 2019 Aug - Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise.
Xu Fengrui et al. JCO clinical cancer informatics 2019 Aug 31-15 - Breast cancer risk assessment: Evaluation of screening tools for genetics referral.
Himes Deborah O et al. Journal of the American Association of Nurse Practitioners 2019 Aug - ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers.
Abdel-Fatah Tarek M A et al. Cancers 2019 Aug 11(8) - Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Kleiblov? Petra et al. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32(Supplementum2) 36-50 - Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study.
West Allison H et al. Cancer medicine 2019 Aug - A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
Brentnall Adam R et al. Journal of breast imaging 2019 Jun 1(2) 99-106 - BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.
Bu Hualei et al. The journal of obstetrics and gynaecology research 2019 Aug
.png)
No hay comentarios:
Publicar un comentario